Zinc as an essential element for normal immune reactions and as a therapeutic agent for autoimmune diseases

Authors

  • Inas K. Sharquie Associate Prof. Dr. Inas K. Sharquie PhD. Department of Microbiology & Immunology, College of Medicine, University of Baghdad, Baghdad, Iraq.
  • Khalifa E. Sharquie Prof Dr. Khalifa E. Sharquie, MD, PhD, FRCP Edin. Department of Dermatology, College of Medicine, University of Baghdad, Baghdad, Iraq.
  • Wasan W. Al-bassam Lecturer Dr. Wasan W. Al-bassam PhD. Department of Biotechnology, College of Science, University of Baghdad, Baghdad, Iraq.

DOI:

https://doi.org/10.66344/jpad.32.4.2022.1991

Abstract

Zinc is an essential element that is involved in more than 300 enzymes metabolism. Also, zinc is engaged in the function of many immunological processes as zinc deficiency leads to a reduction in T-cells, altered T-cell differentiation, and suppression of their functions. zinc deficiency causes impairment of the immune system, increased susceptibility to infections, and an escalation to chronic inflammation if untreated. In addition, there are many studies that had been carried out and showed that zinc is an important therapeutic agent in the treatment of many cuteness and systemic disease either in a form of topical zinc cream or through oral zinc sulfates like in the therapy of alopecia areata, vitiligo, psoriasis, and systemic sclerosis. So the aim of this review is to illustrate and highlight the role of zinc in health and disease.

Downloads

Published

2022-12-08

How to Cite

1.
Sharquie IK, Sharquie KE, Al-bassam WW. Zinc as an essential element for normal immune reactions and as a therapeutic agent for autoimmune diseases. J Pak Assoc Dermatol [Internet]. 2022Dec.8 [cited 2026Apr.12];32(4):719-25. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/1991

Issue

Vol. 32 No. 4 (2022): October - December

Section

Review Articles

License

Submission declaration

Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.

By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.

Most read articles by the same author(s)